Respirerx Pharmaceuticals Stock Market Value
| RSPI Stock | USD 0 0.00 0.00% |
| Symbol | RespireRx |
RespireRx Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to RespireRx Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of RespireRx Pharmaceuticals.
| 12/13/2025 |
| 01/12/2026 |
If you would invest 0.00 in RespireRx Pharmaceuticals on December 13, 2025 and sell it all today you would earn a total of 0.00 from holding RespireRx Pharmaceuticals or generate 0.0% return on investment in RespireRx Pharmaceuticals over 30 days. RespireRx Pharmaceuticals is related to or competes with Comjoyful International. RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the t... More
RespireRx Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure RespireRx Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess RespireRx Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0775 | |||
| Maximum Drawdown | 102.53 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 20.0 |
RespireRx Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for RespireRx Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as RespireRx Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use RespireRx Pharmaceuticals historical prices to predict the future RespireRx Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.073 | |||
| Jensen Alpha | 0.9703 | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | 3.45 |
RespireRx Pharmaceuticals Backtested Returns
RespireRx Pharmaceuticals is out of control given 3 months investment horizon. RespireRx Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12 % return per unit of risk over the last 3 months. We were able to interpolate data for eighteen different technical indicators, which can help you to evaluate if expected returns of 1.37% are justified by taking the suggested risk. Use RespireRx Pharmaceuticals Risk Adjusted Performance of 0.073, coefficient of variation of 1169.03, and Variance of 137.93 to evaluate company specific risk that cannot be diversified away. RespireRx Pharmaceuticals holds a performance score of 9 on a scale of zero to a hundred. The company holds a Beta of 0.29, which implies not very significant fluctuations relative to the market. As returns on the market increase, RespireRx Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding RespireRx Pharmaceuticals is expected to be smaller as well. Use RespireRx Pharmaceuticals maximum drawdown and rate of daily change , to analyze future returns on RespireRx Pharmaceuticals.
Auto-correlation | 1.00 |
Perfect predictability
RespireRx Pharmaceuticals has perfect predictability. Overlapping area represents the amount of predictability between RespireRx Pharmaceuticals time series from 13th of December 2025 to 28th of December 2025 and 28th of December 2025 to 12th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of RespireRx Pharmaceuticals price movement. The serial correlation of 1.0 indicates that 100.0% of current RespireRx Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
RespireRx Pharmaceuticals lagged returns against current returns
Autocorrelation, which is RespireRx Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting RespireRx Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of RespireRx Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that RespireRx Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
RespireRx Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If RespireRx Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if RespireRx Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in RespireRx Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
RespireRx Pharmaceuticals Lagged Returns
When evaluating RespireRx Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of RespireRx Pharmaceuticals pink sheet have on its future price. RespireRx Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, RespireRx Pharmaceuticals autocorrelation shows the relationship between RespireRx Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in RespireRx Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in RespireRx Pink Sheet
RespireRx Pharmaceuticals financial ratios help investors to determine whether RespireRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RespireRx with respect to the benefits of owning RespireRx Pharmaceuticals security.